Mirvetuximab soravtansine Interactions
There are 144 drugs known to interact with mirvetuximab soravtansine, along with 4 disease interactions. Of the total drug interactions, 28 are major, 115 are moderate, and 1 is minor.
Medications known to interact with mirvetuximab soravtansine
Note: Showing generic names only.
A
- adalimumab
- ado-trastuzumab emtansine
- amiodarone
- amprenavir
- atazanavir
- atezolizumab
- atorvastatin
- auranofin
- aurothioglucose
- avelumab
- axicabtagene ciloleucel
B
C
- cabazitaxel
- carboplatin
- carfilzomib
- cemiplimab
- ceritinib
- cerivastatin
- certolizumab
- chloramphenicol
- chloroquine
- ciltacabtagene autoleucel
- cisplatin
- clarithromycin
- cobicistat
- colchicine
- conivaptan
- crizotinib
D
- dapsone
- delavirdine
- deucravacitinib
- didanosine
- dinutuximab
- disulfiram
- docetaxel
- dostarlimab
- durvalumab
E
- elotuzumab
- elranatamab
- enfortumab vedotin
- eribulin
- etanercept
- ethambutol
- ethionamide
- etoposide
- etravirine
F
G
H
I
- idecabtagene vicleucel
- idelalisib
- indinavir
- infliximab
- interferon alfa-2a
- interferon alfa-2b
- interferon alfa-n1
- interferon alfacon-1
- iodoquinol
- ipilimumab
- isoniazid
- itraconazole
- ixabepilone
- ixazomib
K
L
M
N
O
P
- paclitaxel
- paclitaxel protein-bound
- peginterferon alfa-2a
- peginterferon alfa-2b
- pembrolizumab
- pitavastatin
- polatuzumab vedotin
- pomalidomide
- ponatinib
- posaconazole
- pravastatin
- pretomanid
R
S
T
- talquetamab
- tarlatamab
- teclistamab
- telaprevir
- telbivudine
- telithromycin
- teniposide
- teriflunomide
- thalidomide
- tinidazole
- tisagenlecleucel
- tislelizumab
- tisotumab vedotin
- tocilizumab
- toripalimab
- trabectedin
- tremelimumab
- troleandomycin
- tucatinib
V
Z
Mirvetuximab soravtansine disease interactions
There are 4 disease interactions with mirvetuximab soravtansine which include:
More about mirvetuximab soravtansine
- mirvetuximab soravtansine consumer information
- Compare alternatives
- Reviews (10)
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.